Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1

Glen S Hazlewood; Pooneh Akhavan; Jordi Pardo Pardo; Arnav Agarwal; Orit Schieir; Claire E H Barber; Laurie Proulx; Dawn P Richards; Claire Bombardier; Janet E Pope; Cheryl Barnabe; Peter Tugwell; Shahin Jamal; J Carter Thorne; Roko P A Nikolic; Majed Khraishi; Nick Bansback; Alexandra Legge; Vivian Bykerk; Regina Taylor-Gjevre

doi:10.3899/jrheum.2023-0625

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1

J Rheumatol. 2023 Sep;50(9):1198-1199. doi: 10.3899/jrheum.2023-0625. Epub 2023 Aug 1.

Authors

Glen S Hazlewood^{1

2}, Pooneh Akhavan³, Jordi Pardo Pardo⁴, Arnav Agarwal^{5

6

7}, Orit Schieir⁸, Claire E H Barber^{9

2}, Laurie Proulx¹⁰, Dawn P Richards¹⁰, Claire Bombardier^{11

12}, Janet E Pope¹³, Cheryl Barnabe^{9

2}, Peter Tugwell¹⁴, Shahin Jamal¹⁵, J Carter Thorne¹⁶, Roko P A Nikolic¹⁷, Majed Khraishi¹⁸, Nick Bansback^{2

19}, Alexandra Legge^{2

20}, Vivian Bykerk²¹, Regina Taylor-Gjevre²²

Affiliations

¹ Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; [email protected].
² Arthritis Research Canada, Vancouver, British Columbia, Canada.
³ Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁴ Cochrane Musculoskeletal, University of Ottawa, Ottawa, Ontario, Canada.
⁵ Division of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁶ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
⁷ MAGIC Evidence Ecosystem Foundation, Oslo, Norway.
⁸ Canadian Early Arthritis Cohort Study, Toronto, Ontario, Canada.
⁹ Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
¹⁰ Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada.
¹¹ Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
¹² Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
¹³ Department of Medicine, Western University, Schulich School of Medicine & Dentistry, London, Ontario, Canada.
¹⁴ Department of Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
¹⁵ Division of Rheumatology, University of British Columbia, Arthritis Research Canada, Vancouver, British Columbia, Canada.
¹⁶ The Arthritis Program Research Group, Newmarket, Ontario, Canada.
¹⁷ Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
¹⁸ Department of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
¹⁹ School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
²⁰ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
²¹ Hospital for Special Surgery, Weill Cornell Medicine (Cornell University), New York, New York, USA.
²² Division of Rheumatology, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatchewan, Manitoba, Canada.

PMID: 37527865
DOI: 10.3899/jrheum.2023-0625

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Canada
Humans
Rheumatology*
Treatment Outcome
Tumor Necrosis Factor-alpha

Substances

Antirheumatic Agents
Tumor Necrosis Factor-alpha